重症成年幸存者的自杀与自伤:基于人群的队列研究
该研究利用加拿大安大略省2009年1月至2017年12月的关联行政数据库,纳入423 060例连续成人ICU幸存者(平均年龄61.7岁,39%女性),与非ICU住院幸存者比较。ICU幸存者自杀、自伤及复合终点粗发生率分别为41.4、327.9、361.0/10万人年,非ICU住院幸存者分别为16.8、177.3、191.6/10万人年。加权模型显示ICU幸存者自杀风险(aHR 1.22,95%CI 1.11–1.33)和自伤风险(aHR 1.15,95%CI 1.12–1.19)均更高。既往抑郁或焦虑(aHR 5.69,95%CI 5.38–6.02)、既往PTSD(aHR 1.87,95%CI 1.64–2.13)、有创机械通气(aHR 1.45,95%CI 1.38–1.54)和肾脏替代治疗(aHR 1.35,95%CI 1.17–1.56)与自杀或自伤相关。作者认为了解这些预后因素可能有助于早期干预。
要点
- ICU幸存者自杀粗发生率为41.4/10万人年,非ICU住院幸存者为16.8/10万人年;自伤分别为327.9 vs 177.3/10万人年。
- 加权模型显示ICU幸存者较非ICU住院幸存者自杀风险升高(aHR 1.22,95%CI 1.11–1.33),自伤风险升高(aHR 1.15,95%CI 1.12–1.19)。
- ICU幸存者中既往抑郁或焦虑与自杀或自伤风险升高相关(aHR 5.69,95%CI 5.38–6.02)。
- 既往PTSD(aHR 1.87,95%CI 1.64–2.13)、有创机械通气(aHR 1.45,95%CI 1.38–1.54)、肾脏替代治疗(aHR 1.35,95%CI 1.17–1.56)与自杀或自伤相关。
- 作者认为了解这些预后因素可能有助于早期干预,以潜在减少这一重要公共卫生问题。
适用人群与场景
- 连续成人ICU幸存者(≥18岁),以指数住院期间是否入住ICU分为ICU幸存者与非ICU住院幸存者。
- 研究场景为加拿大安大略省2009年1月至2017年12月(含首尾)出院后的随访。
研究设计与关键结果
- 基于人群的队列研究,利用关联且经过验证的省级数据库,纳入423 060例连续成人ICU幸存者(平均年龄61.7岁,39%女性)。
- ICU幸存者自杀、自伤及自杀或自伤复合终点粗发生率分别为41.4、327.9、361.0/10万人年;非ICU住院幸存者分别为16.8、177.3、191.6/10万人年。
- 采用重叠倾向评分加权、病因特异性Cox比例风险模型分析,ICU幸存者较非ICU住院幸存者自杀风险升高(aHR 1.22,95%CI 1.11–1.33),自伤风险升高(aHR 1.15,95%CI 1.12–1.19)。
- ICU幸存者中,既往抑郁或焦虑与自杀或自伤相关(aHR 5.69,95%CI 5.38–6.02),既往PTSD相关(aHR 1.87,95%CI 1.64–2.13),有创机械通气相关(aHR 1.45,95%CI 1.38–1.54),肾脏替代治疗相关(aHR 1.35,95%CI 1.17–1.56)。
- 自杀发生率的评估考虑了其他原因死亡的竞争风险。
证据类型、等级与局限
- 证据类型:基于人群的队列研究,使用关联且经过验证的省级行政数据库。
- 局限:原文未报告局限性
对床旁实践的改变
- 对ICU幸存者出院后评估自杀与自伤风险时,可将既往抑郁或焦虑、既往PTSD、住院期间有创机械通气及肾脏替代治疗作为风险分层因素(作者认为了解这些预后因素可能有助于早期干预)。
- 原文未据此给出具体干预措施或随访方案推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To analyse the association between survival from critical illness and suicide or self-harm after hospital discharge.
DESIGN: Population based cohort study using linked and validated provincial databases.
SETTING: Ontario, Canada between January 2009 and December 2017 (inclusive).
PARTICIPANTS: Consecutive adult intensive care unit (ICU) survivors (≥18 years) were included. Linked administrative databases were used to compare ICU hospital survivors with hospital survivors who never required ICU admission (non-ICU hospital survivors). Patients were categorised based on their index hospital admission (ICU or non-ICU) during the study period.
MAIN OUTCOME MEASURES: The primary outcome was the composite of death by suicide (as noted in provincial death records) and deliberate self-harm events after discharge. Each outcome was also assessed independently. Incidence of suicide was evaluated while accounting for competing risk of death from other causes. Analyses were conducted by using overlap propensity score weighted, cause specific Cox proportional hazard models.
RESULTS: 423 060 consecutive ICU survivors (mean age 61.7 years, 39% women) were identified. During the study period, the crude incidence (per 100 000 person years) of suicide, self-harm, and the composite of suicide or self-harm among ICU survivors was 41.4, 327.9, and 361.0, respectively, compared with 16.8, 177.3, and 191.6 in non-ICU hospital survivors. Analysis using weighted models showed that ICU survivors (v non-ICU hospital survivors) had a higher risk of suicide (adjusted hazards ratio 1.22, 95% confidence interval 1.11 to 1.33) and self-harm (1.15, 1.12 to 1.19). Among ICU survivors, several factors were associated with suicide or self-harm: previous depression or anxiety (5.69, 5.38 to 6.02), previous post-traumatic stress disorder (1.87, 1.64 to 2.13), invasive mechanical ventilation (1.45, 1.38 to 1.54), and renal replacement therapy (1.35, 1.17 to 1.56).
CONCLUSIONS: Survivors of critical illness have increased risk of suicide and self-harm, and these outcomes were associated with pre-existing psychiatric illness and receipt of invasive life support. Knowledge of these prognostic factors might allow for earlier intervention to potentially reduce this important public health problem.
参考来源
- Fernando SM, Qureshi D, Sood MM, et al. Suicide and self-harm in adult survivors of critical illness: population based cohort study. BMJ. 2021. PMID: 33952509. doi:10.1136/bmj.n973
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。